Results of a randomized double-blind trial which were presented at the Heart Failure 2013 congress reveal that the drug, Coenzyme Q10, decreases all -ause mortality by half. It is the first drug to improve heart failure mortality in over a decade and should be added to standard treatment, according to lead author Professor Svend Aage Mortensen (Copenhagen, Denmark). Heart Failure 2013 is being held from 25-28 May in Lisbon, Portugal. It is the main annual ...Sunday, 26 May 2013
New Drug Cuts Down Mortality Among Heart Failure Patients in Half
Results of a randomized double-blind trial which were presented at the Heart Failure 2013 congress reveal that the drug, Coenzyme Q10, decreases all -ause mortality by half. It is the first drug to improve heart failure mortality in over a decade and should be added to standard treatment, according to lead author Professor Svend Aage Mortensen (Copenhagen, Denmark). Heart Failure 2013 is being held from 25-28 May in Lisbon, Portugal. It is the main annual ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment